These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17371023)

  • 21. Developing Equipotent Teixobactin Analogues against Drug-Resistant Bacteria and Discovering a Hydrophobic Interaction between Lipid II and Teixobactin.
    Zong Y; Sun X; Gao H; Meyer KJ; Lewis K; Rao Y
    J Med Chem; 2018 Apr; 61(8):3409-3421. PubMed ID: 29629769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual Mode of Action for Plusbacin A
    O'Connor RD; Singh M; Chang J; Kim SJ; VanNieuwenhze M; Schaefer J
    J Phys Chem B; 2017 Feb; 121(7):1499-1505. PubMed ID: 28135800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-natural aglycones of glycopeptide antibiotics of the vancomycin group. Synthesis and antibacterial activity].
    Pavlov AIu; Olsuf'eva EN; Miroshnikova OV; Reznikova MI; Lazhko EI; Malabarba A; Ciabatti R; Preobrazhenskaia MN
    Bioorg Khim; 1997 May; 23(5):410-21. PubMed ID: 9290051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria.
    Nakama Y; Yoshida O; Yoda M; Araki K; Sawada Y; Nakamura J; Xu S; Miura K; Maki H; Arimoto H
    J Med Chem; 2010 Mar; 53(6):2528-33. PubMed ID: 20180534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipophilic vancomycin aglycon dimer with high activity against vancomycin-resistant bacteria.
    Yarlagadda V; Sarkar P; Manjunath GB; Haldar J
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5477-80. PubMed ID: 26525861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triketones active against antibiotic-resistant bacteria: synthesis, structure-activity relationships, and mode of action.
    van Klink JW; Larsen L; Perry NB; Weavers RT; Cook GM; Bremer PJ; MacKenzie AD; Kirikae T
    Bioorg Med Chem; 2005 Dec; 13(24):6651-62. PubMed ID: 16140015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teixobactin and Its Analogues: A New Hope in Antibiotic Discovery.
    Fiers WD; Craighead M; Singh I
    ACS Infect Dis; 2017 Oct; 3(10):688-690. PubMed ID: 28770988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total synthesis and assignment of the side chain stereochemistry of LI-F04a: an antimicrobial cyclic depsipeptide.
    Cochrane JR; McErlean CS; Jolliffe KA
    Org Lett; 2010 Aug; 12(15):3394-7. PubMed ID: 20608662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple attack on bacteria by the new antibiotic teixobactin.
    von Nussbaum F; Süssmuth RD
    Angew Chem Int Ed Engl; 2015 Jun; 54(23):6684-6. PubMed ID: 25968231
    [No Abstract]   [Full Text] [Related]  

  • 30. [Progress in the study of some important natural bioactive cyclopeptides].
    Xu WY; Zhao SM; Zeng GZ; He WJ; Xu HM; Tan NH
    Yao Xue Xue Bao; 2012 Mar; 47(3):271-9. PubMed ID: 22645749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Glycopeptide antibiotics resistance mechanism as the basis for novel derivatives development capable to overcome resistance].
    Trenin AS; Olsuf'eva EN
    Bioorg Khim; 1997 Nov; 23(11):851-67. PubMed ID: 9518425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Old approach yields new antibiotic.
    Blanchard JS
    Nat Med; 2005 Oct; 11(10):1045-6. PubMed ID: 16211032
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipodepsipeptide antibiotic fusaricidin and its analogues. Total solid-phase and biological activity.
    Stawikowski M; Cudic P
    Adv Exp Med Biol; 2009; 611():383-4. PubMed ID: 19400234
    [No Abstract]   [Full Text] [Related]  

  • 34. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria.
    Nakamura J; Yamashiro H; Hayashi S; Yamamoto M; Miura K; Xu S; Doi T; Maki H; Yoshida O; Arimoto H
    Chemistry; 2012 Oct; 18(40):12681-9. PubMed ID: 22915313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternaramide, a cyclic depsipeptide from the marine-derived fungus Alternaria sp. SF-5016.
    Kim MY; Sohn JH; Ahn JS; Oh H
    J Nat Prod; 2009 Nov; 72(11):2065-8. PubMed ID: 19943624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria.
    Lu J; Yoshida O; Hayashi S; Arimoto H
    Chem Commun (Camb); 2007 Jan; (3):251-3. PubMed ID: 17299629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and assignment of stereochemistry of the antibacterial cyclic peptide xenematide.
    Hung KY; Harris PW; Heapy AM; Brimble MA
    Org Biomol Chem; 2011 Jan; 9(1):236-42. PubMed ID: 20949214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives.
    Dixit PP; Nair PS; Patil VJ; Jain S; Arora SK; Sinha N
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3002-5. PubMed ID: 15908210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curing bacteria of antibiotic resistance: reverse antibiotics, a novel class of antibiotics in nature.
    Hiramatsu K; Igarashi M; Morimoto Y; Baba T; Umekita M; Akamatsu Y
    Int J Antimicrob Agents; 2012 Jun; 39(6):478-85. PubMed ID: 22534508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria.
    Bionda N; Pitteloud JP; Cudic P
    Future Med Chem; 2013 Jul; 5(11):1311-30. PubMed ID: 23859209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.